The goal of this study is to test a home-based and patient-tailored cognitive training intervention among gynecologic cancer patients who have completed chemotherapy and who have experienced cancer-related cognitive impairment.
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Female; ≥18 years of age
* Presents to clinic with a confirmed diagnosis of a gynecologic cancer (e.g., ovarian, endometrial, cervical, or vulvar cancer) who have completed adjuvant chemotherapy with at least stable disease at time of screening.
* Screen positive for subjective cognitive impairment by answering affirmatively to at least one of three screener questions
* Fluent in spoken and written English
* Have access to the internet to complete assessments
Exclusion Criteria:
* Patients who have not received chemotherapy
* Patients with pre-existing neuropsychiatric disorders that would impact cognitive function, such as dementia, Alzheimer's disease, and schizophrenia.
* Patients with non-gynecologic causes of incurable metastatic cancers.
* Patients undergoing active interventions in other cognitive trials or patients currently using cognitive training programs such as Brain HQ, Luminosity, Elevate, Peak, Fit Brains, or CogniFit.
* Patients with self-report of learning disability or an unwillingness to participate in technology-based cognitive training programs.
* Pregnant women or prisoners
* Patients with impaired-decision making capacity